Who
James Saccaro
EVP, CFO & COO
Company insider
Files Form 4 as: EVP, CFO & COO, Zoetis; Chief Financial Officer, GE HealthCare Technologies; EVP, Chief Financial Officer, Baxter International.
In numbers
- Trades disclosed
- 71
- Buys
- 1
- Sells
- 0
- Bought
- $401K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 1 Jul 2015
- Last trade
- 31 Aug 2026
- Last filed
- 2 Sep 2026
Companies traded
Activity over time
1 Apr – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Aug 2026filed 2 Sep 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —81,063 at $0.00 | filing |
| 31 Aug 2026filed 2 Sep 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —81,063 at $0.00 | filing |
| 1 May 2026filed 1 May 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Bought | $201K3,310 at $60.60 | filing |
| 1 May 2026filed 1 May 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Bought | $201K3,310 at $60.60 | filing |
| 2 Mar 2026filed 4 Mar 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —12,475 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | GEHC GE HealthCare Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —32,797 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | GEHC GE HealthCare Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —32,797 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —12,475 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —22,610 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $679K8,570 at $79.20 | filing |
| 12 Feb 2026filed 17 Feb 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —22,610 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $679K8,570 at $79.20 | filing |
| 1 Feb 2026filed 3 Feb 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $75K948 at $78.97 | filing |
| 1 Feb 2026filed 3 Feb 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $75K948 at $78.97 | filing |
| 1 Sep 2025filed 3 Sep 2025 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $128K1,740 at $73.73 | filing |
| 1 Sep 2025filed 3 Sep 2025 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $110K1,498 at $73.73 | filing |
| 1 Jun 2025filed 3 Jun 2025 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $685K9,712 at $70.54 | filing |
| 3 Mar 2025filed 5 Mar 2025 | GEHC GE HealthCare Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —32,252 at $0.00 | filing |
| 3 Mar 2025filed 5 Mar 2025 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —11,278 at $0.00 | filing |
| 1 Feb 2025filed 4 Feb 2025 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $82K934 at $88.30 | filing |
News
GE HealthCare Technologies (GEHC) vs. DHR and MDT: Can a $23.9B Backlog and AI Innovation Drive a Healthcare Re-Rating?GEHC · insidermonkey.com · 22 Oct 2026Analyzing GE HealthCare Technologies (NASDAQ:GEHC) & AxoGen (NASDAQ:AXGN)GEHC · tickerreport.com · 21 Oct 2026Stock Traders Buy High Volume of Call Options on GE HealthCare Technologies (NASDAQ:GEHC)GEHC · dailypolitical.com · 12 Oct 2026
0 headlines in the last 90 days name James Saccaro; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.